NCT02872792 (MUEVELO) is a NA clinical trial of Early mobilisation with cyclo ergometer in Sepsis, sponsored by University Hospital, Rouen.

Who is sponsoring NCT02872792?

NCT02872792 is sponsored by University Hospital, Rouen.

What drugs are being tested in NCT02872792?

Interventions in NCT02872792: Early mobilisation with cyclo ergometer, Standard physiotherapy.

Is NCT02872792 still recruiting?

NCT02872792 is currently terminated. Last updated 29 March 2022.

Last reviewed 2022-03-29 · How we verify

NCT02872792: MUEVELO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Early Mobilisation in Intensive Care Unit : Interest of Cyclo-ergometry in Patients With Septic Chock

Terminated NA Last updated 29 March 2022

What this trial tests

NA trial testing Early mobilisation with cyclo ergometer in Sepsis in 122 participants. Terminated before completion.

Timeline

14 December 2016

Primary endpoint
21 April 2020

21 April 2020

Quick facts

Lead sponsor	University Hospital, Rouen
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	122
Start date	14 December 2016
Primary completion	21 April 2020
Estimated completion	21 April 2020
Sites	1 location across France

Drugs / interventions tested

Early mobilisation with cyclo ergometer
Standard physiotherapy

Conditions studied

Sepsis — all drugs for Sepsis →

Sponsor

University Hospital, Rouen

Who can join

18 and older, any sex, with Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cycloergometer is a validated method for different care. This kind of device allow passive and active care for patient. The interest of cycloergometer for patient hospitalized in Intensive Care Unit for Sepsis has never been demonstrated. The main objective of this study is to determine the impact of early mobilization by cyclo-ergometer in association with standard physiotherapy, on the ICU length in patients with septic shock The secondary objectives of this study are to assess the impact of early mobilization by cyclo-ergometer in association with standard physiotherapy on: 1. the duration between hemodynamic stability\* and the removal of sedation 2. the duration between the removal of sedation and ICU discharge 3. the mechanical ventilation duration (invasive and noninvasive)

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Early Mobilization Interventions in the Intensive Care Unit: Ongoing and Unpublished Randomized Trials.
Maheswaran J, Fromowitz J, Goldfarb M. · · 2020 · cited 2× · PMID 32399292 · DOI 10.1155/2020/3281394
Early mobilization with or without cycloergometry in patients with septic shock in Intensive Care Unit: a randomized controlled trial.
Michaux B, Harter V, Occhiali E, Astier A, et al · · 2026 · PMID 41938898 · DOI 10.1016/j.aicoj.2026.100034

Verify or expand the search:

Other recruiting trials for Sepsis

Currently open trials in the same condition.

NCT07507877 — Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness · recruiting
NCT07154615 — Assessing Immune Dysfunction in Sepsis · recruiting
NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
NCT07351344 — African Survey on Sepsis Knowledge (ASK) · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting

Other University Hospital, Rouen trials

Trials by the same sponsor.

NCT07441564 — Evaluation of the Efficacy of Ischemic Preconditioning to Protect Against Acute Kidney Injury After Open Surgery for Jux · NA · not yet recruiting
NCT07535944 — Prospective Exploration of Vascular Complications Associated With the Use of Immune Checkpoint Inhibitors · not yet recruiting
NCT07464184 — Evolution of Hypoxic Burden and Sympathetic/Parasympathetic Balance in Patients With Pulmonary Hypertension · NA · not yet recruiting
NCT07359885 — Prediction of Postoperative Pulmonary Complications in Thoracic Surgery · not yet recruiting
NCT07247500 — Impact of Reventilation After One-Lung Ventilation in Thoracic Surgery (OLVREEXP) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02872792 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Rouen
Last refreshed: 29 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02872792.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing